Michael A. Lanphere, V.P. of Legal Affairs at TransBiotec, Inc. (IMLE), bought 5,206,430 shares at $0.10 ($521K) on 2019-08-28, disclosed to the SEC on 2019-09-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.